USD 3.12
(-11.36%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -133.69 Million USD | 20.76% |
2022 | -168.72 Million USD | -420.61% |
2021 | -32.4 Million USD | 80.09% |
2020 | -162.74 Million USD | -63.4% |
2019 | -99.6 Million USD | -96.2% |
2018 | -50.76 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q3 | -16.92 Million USD | -7.75% |
2024 Q1 | -21.76 Million USD | 50.68% |
2024 Q2 | -15.7 Million USD | 27.83% |
2023 Q1 | -33.54 Million USD | 0.48% |
2023 FY | -133.69 Million USD | 20.76% |
2023 Q3 | -27.36 Million USD | 4.54% |
2023 Q2 | -28.67 Million USD | 14.52% |
2023 Q4 | -44.12 Million USD | -61.21% |
2022 Q1 | -44.47 Million USD | -192.3% |
2022 Q2 | -35.8 Million USD | 19.51% |
2022 FY | -168.72 Million USD | -420.61% |
2022 Q4 | -33.7 Million USD | 38.43% |
2022 Q3 | -54.74 Million USD | -52.91% |
2021 Q2 | -2.94 Million USD | -326.38% |
2021 FY | -32.4 Million USD | 80.09% |
2021 Q4 | -15.21 Million USD | -12.2% |
2021 Q3 | -13.56 Million USD | -360.94% |
2021 Q1 | -690 Thousand USD | 96.99% |
2020 Q1 | -24.35 Million USD | 39.47% |
2020 Q4 | -22.94 Million USD | 75.12% |
2020 Q3 | -92.2 Million USD | -296.75% |
2020 Q2 | -23.24 Million USD | 4.57% |
2020 FY | -162.74 Million USD | -63.4% |
2019 FY | -99.6 Million USD | -96.2% |
2019 Q4 | -40.23 Million USD | 0.0% |
2018 FY | -50.76 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Abbott Laboratories | 5.72 Billion USD | 102.336% |
Allurion Technologies Inc. | -82.3 Million USD | -62.447% |
Artivion, Inc. | -30.69 Million USD | -335.647% |
Avanos Medical, Inc. | -61.8 Million USD | -116.343% |
Butterfly Network, Inc. | -133.69 Million USD | -0.0% |
Bio-Rad Laboratories, Inc. | -637.32 Million USD | 79.022% |
Boston Scientific Corporation | 1.59 Billion USD | 108.393% |
Perspective Therapeutics, Inc. | -14.67 Million USD | -811.384% |
CONMED Corporation | 64.45 Million USD | 307.419% |
Edwards Lifesciences Corporation | 1.4 Billion USD | 109.534% |
Paragon 28, Inc. | -47.84 Million USD | -179.467% |
Glaukos Corporation | -134.66 Million USD | 0.714% |
Globus Medical, Inc. | 122.87 Million USD | 208.812% |
Inspire Medical Systems, Inc. | -21.15 Million USD | -532.062% |
Integer Holdings Corporation | 90.65 Million USD | 247.49% |
Medtronic plc | 3.67 Billion USD | 103.637% |
Nevro Corp. | -92.21 Million USD | -44.99% |
Owlet, Inc. | -32.9 Million USD | -306.371% |
Penumbra, Inc. | 90.95 Million USD | 246.997% |
Vicarious Surgical Inc. | -71.07 Million USD | -88.122% |
Smith & Nephew plc | 263 Million USD | 150.837% |
Sonendo, Inc. | -60.91 Million USD | -119.472% |
STERIS plc | 378.23 Million USD | 135.348% |
Stryker Corporation | 3.16 Billion USD | 104.224% |
Vapotherm, Inc. | -58.19 Million USD | -129.753% |
Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | 113.057% |